Metabolic dysfunction‐associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle‐aged and older US population-Reference-Cited by-同舟云学术

Metabolic dysfunction‐associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle‐aged and older US population

Published:2021-11-21 Issue:2 Volume:52 Page:176-186
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Yang Sheng¹,Cheng Jiawen²,Zhang Rui³,Sun Huiwen⁴,Zhang Hui³,Lyu Sali²⁵,Duan Weiwei¹²⁵^ORCID

Affiliation:

1. Department of Epidemiology and Biostatistics Center for Global Health School of Public Health Nanjing Medical University Nanjing China

2. Department of Bioinformatics School of Biomedical Engineering and Informatics Nanjing Medical University Nanjing China

3. Hepatobiliary Center The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology Chinese Academy of Medical Sciences Nanjing China

4. Department of Geriatrics Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing China

5. Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment Collaborative Innovation Center for Personalized Cancer Medicine Nanjing Medical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13728

Reference66 articles.

1. The global NAFLD epidemic

2. Nonalcoholic Fatty Liver Disease

3. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study